Biocept reports inducement grants under nasdaq listing rule 5635(c)(4)

San diego, dec. 31, 2020 /prnewswire/ -- biocept, inc. (nasdaq: bioc), a leading commercial provider of molecular diagnostic assays, products and services designed to provide physicians with clinically actionable information to improve patient outcomes, today announced that it has granted...
BIOC Ratings Summary
BIOC Quant Ranking